ABVCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ECOC
ABVC BIOPHARMA, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$0.91−0.01 (-0.86%)
Close on Oct 19, 2026
- Market cap
- $23.71M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Abvc Biopharma has not reported a dividend
No dividend per share appears in Abvc Biopharma's annual filings since fiscal 2010.